Prostacyclin treatment and clinical outcome in severe traumatic brain injury patients managed with an ICP-targeted therapy: A prospective study

References

• Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith KR, Jr, Muizelaar JP, Wagner FC, Jr, Marion DW, Luerssen TG, et al. Lack of effect of induction of hypothermia after acute brain injury. New England Journal of Medicine 2001; 344: 556–563
   PubMed Web of Science ®Google Scholar
• Corral L, Ventura JL, Herrero JI, Monfort JL, Juncadella M, Gabarros A, Bartolome C, Javierre CF, Garcia-Huete L. Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury. Brain Injury 2007; 21: 1225–1231
   PubMed Web of Science ®Google Scholar
• Papa L, Akinyi L, Liu MC, Pineda JA, Tepas JJ, 3rd, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Critical Care in Medicine 2009; 38: 138–144
   Google Scholar
• Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. Journal of the American Medical Association 1996; 276: 538–543
   PubMed Web of Science ®Google Scholar
• Asgeirsson B, Grände PO, Nordström CH. A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Medicine 1994; 20: 260–267
   PubMed Web of Science ®Google Scholar
• Grände PO, Asgeirsson B, Nordström CH. Physiologic principles for volume regulation of a tissue enclosed in a rigid shell with application to the injured brain. Journal of Trauma 1997; 42: 23–31
   Google Scholar
• Grände PO, Asgeirsson B, Nordström CH. Volume-targeted therapy of increased intracranial pressure: The Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiologica Scandinavica 2002; 46: 929–941
   PubMedGoogle Scholar
• Naredi S, Eden E, Zäll S, Stephensen H, Rydenhag B. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: Clinical results. Intensive Care Medicine 1998; 24: 446–451
   PubMed Web of Science ®Google Scholar
• Naredi S, Olivecrona M, Lindgren C, Östlund AL, Grände PO, Koskinen LO. An outcome study of severe traumatic head injury using the “Lund therapy” with low-dose prostacyclin. Acta Anaesthesiologica Scandinavica 2001; 45: 402–406
   PubMedGoogle Scholar
• Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO. Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy. Journal of Neurotrauma 2007; 24: 927–935
   PubMed Web of Science ®Google Scholar
• Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen L-OD. Prostacylin treatment in severe traumatic brain injury - a microdialysis and outcome study. Journal of Neurotrauma 2009; 26: 1251–1262
   PubMedGoogle Scholar
• Scherer W, Uekötter B, Hoffmann A, Sephernia A. Ten years experiences with the Lund concept and early rehabilitation in patients with severe traumatic brain injury. European Journal of Anaestesiology 2008; 25(Suppl 43)7
   Google Scholar
• Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998; 15: 573–585
   PubMed Web of Science ®Google Scholar
• Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480–484
   PubMed Web of Science ®Google Scholar
• Marshall LF, Marshall SB, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Journal of Neurosurgery 1991; 75: S14–S20
   Web of Science ®Google Scholar
• Eker C, Asgeirsson B, Grände PO, Schalen W, Nordström CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Critical Care in Medicine 1998; 26: 1881–1886
   PubMedGoogle Scholar
• Roozenbeek B, Maas AI, Marmarou A, Butcher I, Lingsma HF, Lu J, McHugh GS, Murray GD, Steyerberg EW. The influence of enrollment criteria on recruitment and outcome distribution in traumatic brain injury studies: Results from the impact study. Journal of Neurotrauma 2009; 26: 1069–1075
   PubMedGoogle Scholar
• Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, et al. A trial of the effect of nimodipine on outcome after head injury. Acta Neurochirurgica (Wien) 1991; 110: 97–105
   PubMed Web of Science ®Google Scholar
• Joosse P, Smit G, Arendshorst RJ, Soedarmo S, Ponsen KJ, Goslings JC. Outcome and prognostic factors of traumatic brain injury: A prospective evaluation in a Jakarta University hospital. Journal of Clinical Neuroscience 2009; 16: 925–928
   PubMedGoogle Scholar
• Maas AI, Murray G, Henney H, 3rd, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N. Efficacy and safety of dexanabinol in severe traumatic brain injury: Results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol 2006; 5: 38–45
   PubMed Web of Science ®Google Scholar
• Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. Journal of Neurosurgery 1998; 89: 519–525
   PubMed Web of Science ®Google Scholar
• Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, Rigo LA, Bertotti MM, Gullo J, Hohl A, Dal-Pizzol F, et al. Mortality in severe traumatic brain injury: A multivariated analysis of 748 Brazilian patients from Florianopolis City. Journal of Trauma 2009; 67: 85–90
   PubMed Web of Science ®Google Scholar
• Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF. Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: Results of two phase III clinical trials. The Selfotel Investigators. Journal of Neurosurgery 1999; 91: 737–743
   PubMed Web of Science ®Google Scholar
• Murray GD, Teasdale GM, Braakman R, Cohadon F, Dearden M, Iannotti F, Karimi A, Lapierre F, Maas A, Ohman J, et al. The European Brain Injury Consortium survey of head injuries. Acta Neurochirurgica (Wien) 1999; 141: 223–236
   PubMed Web of Science ®Google Scholar
• Murray LS, Teasdale GM, Murray GD, Miller DJ, Pickard JD, Shaw MD. Head injuries in four British neurosurgical centres. British Journal of Neurosurgery 1999; 13: 564–569
   PubMed Web of Science ®Google Scholar
• Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: A randomized controlled trial. Critical Care 2008; 12: R61
   PubMed Web of Science ®Google Scholar
• Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: Results of a multi-center, randomized, placebo-controlled trial. American Brain Injury Consortium Study Group. Journal of Neurotrauma 1999; 16: 431–444
   PubMed Web of Science ®Google Scholar
• El-Adawy Y, Rosner M. Cerebral perfusion pressure, autoregulation and the PVI reflection point: Pathological ICP. Intracranial pressure VII, J Hoff, A Betz. Springer-Verlag, Berlin Heidelberg 1989; 829–833
   Google Scholar
• Gray WJ, Rosner MJ. Pressure-volume index as a function of cerebral perfusion pressure. Part 1: The effects of cerebral perfusion pressure changes and anesthesia. Journal of Neurosurgery 1987; 67: 369–376
   PubMedGoogle Scholar
• McGraw C. A cerebral perfusion pressure greater than 80 mm Hg is more beneficial. Intracranial pressure VII, J Hoff, A Betz. Springer Verlag, Berlin Heidelberg 1989; 839–841
   Google Scholar
• Rosner MJ, Daughton S, Cerebral perfusion pressure management in head injury. Journal of Trauma 1990;30:933–940; discussion 940–931
   Google Scholar
• Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: Management protocol and clinical results. Journal of Neurosurgery 1995; 83: 949–962
   PubMed Web of Science ®Google Scholar
• Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW, Rosenthal G, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. Journal of Neurotrauma 2007; 24(Suppl 1)59–64
   PubMedGoogle Scholar
• Balestreri M, Czosnyka M, Hutchinson P, Steiner LA, Hiler M, Smielewski P, Pickard JD. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocritical Care 2006; 4: 8–13
   PubMed Web of Science ®Google Scholar
• Palmer S, Bader MK, Qureshi A, Palmer J, Shaver T, Borzatta M, Stalcup C. The impact on outcomes in a community hospital setting of using the AANS traumatic brain injury guidelines. Americans Associations for Neurologic Surgeons. Journal of Trauma 2001; 50: 657–664
   PubMedGoogle Scholar
• Patel HC, Bouamra O, Woodford M, King AT, Yates DW, Lecky FE. Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: An observational study. Lancet 2005; 366: 1538–1544
   PubMed Web of Science ®Google Scholar
• Olivecrona M, Zetterlund B, Rodling-Wahlstrom M, Naredi S, Koskinen LO. Absence of electroencephalographic seizure activity in patients treated for head injury with an intracranial pressure-targeted therapy. Journal of Neurosurgery 2009; 110: 300–305
   PubMedGoogle Scholar